Curis
CRIS
#11172
Rank
A$2.8 M
Marketcap
A$1.15
Share price
-3.73%
Change (1 day)
-52.62%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): A-$20.04

According to Curis's latest financial reports the company's current EPS (TTM) is A-$20.44. In 2025 the company made an earnings per share (EPS) of A-$34.22 an increase over its 2024 EPS that were of A-$202.08.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$20.04-41.45%
2025A-$34.22-83.07%
2024A-$202.08-22.15%
2023A-$259.58-26.17%
2022A-$351.5622.3%
2021A-$287.46-25.37%
2020A-$385.20-30.93%
2019A-$557.67-2.02%
2018A-$569.17
2016A-$1,294-10%
2015A-$1,437138.1%
2014A-$603.6740%
2013A-$431.19-25%
2012A-$574.9266.67%
2011A-$344.95

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.09-105.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.53-131.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.52-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$4.74-123.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$6.25-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A-$4.57-77.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A-$4.94-75.81%๐Ÿ‡บ๐Ÿ‡ธ USA